Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
27.8M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
4.8M
-
Shares change
-
-4.08M
-
Total reported value, excl. options
-
$125M
-
Value change
-
-$83.3M
-
Put/Call ratio
-
1.99
-
Number of buys
-
59
-
Number of sells
-
-14
-
Price
-
$26.00
Significant Holders of Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) as of Q2 2014
87 filings reported holding AXDX - Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share as of Q2 2014.
Accelerate Diagnostics, Inc. - Common Stock, par value $0.001 per share (AXDX) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.8M shares
of 27.8M outstanding shares and own 17.25% of the company stock.
Largest 10 shareholders include FIRST REPUBLIC INVESTMENT MANAGEMENT, INC. (793K shares), VANGUARD GROUP INC (594K shares), BlackRock Fund Advisors (501K shares), State Street Corp (306K shares), BlackRock Institutional Trust Company, N.A. (277K shares), Wood Investment Counsel LLC (277K shares), SANDLER CAPITAL MANAGEMENT (200K shares), NORTHERN TRUST CORP (184K shares), GEODE CAPITAL MANAGEMENT, LLC (141K shares), and JANE STREET GROUP, LLC (120K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.